Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,394 | -2,266 | -818 | -2,667 | -1,801 |
| Depreciation Amortization | 353 | 351 | 1 | 323 | 308 |
| Other Working Capital | 2,057 | 1,548 | 617 | 308 | -352 |
| Other Operating Activity | 301 | 26 | 14 | 232 | 196 |
| Operating Cash Flow | $-683 | $-340 | $-187 | $-1,804 | $-1,649 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -38 | -25 | -5 | -32 | -30 |
| Other Investing Activity | -38 | -25 | -5 | -32 | -30 |
| Investing Cash Flow | $-38 | $-25 | $-5 | $-32 | $-30 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 0 | 1,381 | 1,381 |
| Common Stock Issued | 505 | 115 | 50 | 678 | 600 |
| Financing Cash Flow | $505 | $115 | $50 | $2,059 | $1,981 |
| Beginning Cash Position | 295 | 295 | 295 | 72 | 72 |
| End Cash Position | 80 | 45 | 154 | 295 | 374 |
| Net Cash Flow | $-215 | $-250 | $-142 | $223 | $302 |
| Free Cash Flow | |||||
| Operating Cash Flow | -683 | -340 | -187 | -1,804 | -1,649 |
| Free Cash Flow | -683 | -340 | -187 | -1,804 | -1,649 |